Healthcare -
Biotechnology - NASDAQ - US
$ 0.7817
0.786 %
$ 42.6 M
Market Cap
9.77
P/E
SPRO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SPRO - Spero Therapeutics, Inc.
221 K
LAST VALUE
-94.87%
2 YEAR CAGR
-68.34%
5 YEAR CAGR
0.00%
10 YEAR CAGR